To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in healthy volunteers and patients with symptomatic falciparum malaria
Objective The purpose of this study was to determine the population pharmacokinetics of mefloquin...
Background Low mefloquine exposure has been shown to contribute to treatment failure in patients wit...
The combination of artemether (ARM) and lumefantrine is currently the first-line treatment of uncomp...
AIMS: To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in health...
AIMS: To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in health...
1 The pharmacokinetics, efficacy and toxicity of a new parenteral formulation of halofantrine hydroc...
1. Kenyan children with uncomplicated malaria given oral halofantrine (HF; non-micronised suspension...
pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplic...
The efficacy of the standard formulation of halofantrine hydrochloride has been compromised by the f...
The efficacy of the standard formulation of halofantrine hydrochloride has been compromised by the f...
The current formulation of halofantrine hydrochloride has poor absorption and bioavailability. A new...
Aims To determine the population pharmacokinetics of chlorproguanil, dapsone and the active metabol...
OBJECTIVE: To construct a population pharmacokinetic model for mefloquine in the treatment of falcip...
OBJECTIVE: To construct a population pharmacokinetic model for mefloquine in the treatment of falcip...
Objective\ud \ud The purpose of this study was to determine the population pharmacokinetics of meflo...
Objective The purpose of this study was to determine the population pharmacokinetics of mefloquin...
Background Low mefloquine exposure has been shown to contribute to treatment failure in patients wit...
The combination of artemether (ARM) and lumefantrine is currently the first-line treatment of uncomp...
AIMS: To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in health...
AIMS: To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in health...
1 The pharmacokinetics, efficacy and toxicity of a new parenteral formulation of halofantrine hydroc...
1. Kenyan children with uncomplicated malaria given oral halofantrine (HF; non-micronised suspension...
pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplic...
The efficacy of the standard formulation of halofantrine hydrochloride has been compromised by the f...
The efficacy of the standard formulation of halofantrine hydrochloride has been compromised by the f...
The current formulation of halofantrine hydrochloride has poor absorption and bioavailability. A new...
Aims To determine the population pharmacokinetics of chlorproguanil, dapsone and the active metabol...
OBJECTIVE: To construct a population pharmacokinetic model for mefloquine in the treatment of falcip...
OBJECTIVE: To construct a population pharmacokinetic model for mefloquine in the treatment of falcip...
Objective\ud \ud The purpose of this study was to determine the population pharmacokinetics of meflo...
Objective The purpose of this study was to determine the population pharmacokinetics of mefloquin...
Background Low mefloquine exposure has been shown to contribute to treatment failure in patients wit...
The combination of artemether (ARM) and lumefantrine is currently the first-line treatment of uncomp...
DOI
Add to ORKG